Content » Vol 89, Issue 5

Letter to the Editor

Persistent Expression of CD26/DPPIV After Treatment with Infliximab in Psoriasis Despite Clinical Improvement

Rosanne G. van Lingen, Piet E.J. van Erp, Marieke M.B. Seyger, Elke M.G.J. de Jong, Roelie T. de Boer-van Huizen, Rieke JB Driessen, Peter C.M. van de Kerkhof
DOI: 10.2340/00015555-0675


This article does not have an abstract.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.